Divis Laboratories Pvt Ltd
Divis Labs is one of the Best Pharma Companies in Hyderabad, India in Manufacturing API (Active Pharmaceutical Ingredients), Nutraceutical,
Naproxen, Gabapentin, and Dextromethorphan.
Divis has been established for more than 28 years in Hyderabad and currently has 2 manufacturing units and 11,000 highly trained professionals. And also setting up a manufacturing plant at Kakinada.
Divi’s manufacturing facilities have undergone several audits by Global Regulatory Authorities, various Big Pharma/Multi-National Companies, Statutory Authorities, and Global Environmental, Health and Safety teams. Divi’s specially provides the global pharmaceutical industry with the following reliable, cGMP quality, value-driven solutions for the below-mentioned products:
Divis has been hailed as one of the Top Pharmaceutical Companies in India and acknowledged industry leader in Environment, Health, and Safety. It has quality testing and validation labs.
are fitted with state-of-the-art analytical equipment and testing facilities.
Divi’s continues to be a global leader in Large Volume Generic APIs. The product list includes a very selective 30 APIs that are manufactured commercially in 10’s to 100’s/1000’s of Tonnes each year and continues to be the largest API manufacturer in the world.
Divi’s has achieved this leadership position because of various factors such as backward integration to basic starting materials, dedicated production blocks with large batch sizes and significant capacity creation ahead of time.
A Pharmaceutical Company constantly working to aid people with healthy & peaceful lifestyle.
HQM Pharmaceuticals is leading pharmaceutical company located in Mumbai, and supporting the mankind with affordable & superior quality pharmaceutical products.https://hqmpharma.in/
If you have ever taken an over the counter allergy medication, an oral contraceptive, a generic sleep aid, or any of many, many other pharmaceutical products, you have definitely seen and used pharmaceutical blister packaging.
Pharmaceutical blister packaging consists of two main parts: a plastic front with individual pill pockets molded into it, and a flat piece of backing, likely made of some type of cardboard or foil.
Each pill rests in its own individual pocket, held between the plastic bubble and the foil or cardboard backing, and separated from the rest of the pills.
If you have ever taken medication that came in pharmaceutical blister packaging (and you almost certainly have if you live in the United States), you may have noticed that it can take some effort to get your pill out of its pocket.
You may have even wondered why a company would choose to use such involved packaging.
Well, there are actually multiple reasons pharmaceutical blister packaging is so popular.
Moreover, increasing demand for single-use instruments in disposable applications is anticipated to augment the growth over the projected period.China was the second largest pharmaceutical market in the world, expected to grow USD 173 billion by 2024, growing at a CAGR of 9.1% owing to the requirement of medication & drugs to cure deadly diseases.
Huge investment in biotechnology will primarily drive the growth of the market, as pharma companies deal in innovations for developing medicines and drugs in line with the increasing prevalence of diseases.Browse Details of Report @ https://www.hexaresearch.com/research-report/china-bioprocess-instruments-marketWith the patents of numerous biopharmaceutical products expiring by 2016, the market is anticipated to provide a lucrative opportunity for contract manufacturers operating in the region.
Approval of the trail plan for new drug marketing authorization holder (MAH) in 2016 to produce, conduct clinical trials, and market the products is expected to provide an impetus to the growth of the industry over the next few years.Increasing demand for bioprocess instruments in the pharmaceutical, research & development, industrial and medical laboratories coupled with the increasing number of these facilities is expected to result in the growth of the market.
Change in lifestyle & food consuming habits, and growing levels of air & water pollution have led to increasing occurrence of disease including obesity which has resulted in a rising number of patients diagnosed with cancer, heart disease, diabetes and other chronic conditions.
Thus, the healthcare sector is anticipated to create demand for treatment and laboratory services, which will result in the growth of bioprocess instruments market over the forecast period.Stringent regulatory policies and the high cost of instruments are likely to restrain the bioprocess instruments market in China.
The government has been focusing on reducing the fragmentation in the industry by consolidating manufacturers that lack standards in production with larger companies.
